Clincosm LogoSign in Get a demo

Renal Cancer

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cancer Trial in New York (Magnetic Resonance Imaging (MRI) Scan, Tc-99m Pentetate)

Recruiting
  • Renal Cancer
  • Magnetic Resonance Imaging (MRI) Scan
  • Tc-99m Pentetate
  • New York, New York
    NYU Langone Health
Oct 31, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

Recruiting
  • Metastatic Cancer
  • +5 more
  • Stereotactic Body Radiotherapy
  • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
  • Hartford, Connecticut
  • +9 more
Nov 17, 2022

Kidney Tumor, Renal Cancer Trial in New York (Decision Aid (DA) Web Tool, Institutional Pamphlet)

Recruiting
  • Kidney Tumor
  • Renal Cancer
  • Decision Aid (DA) Web Tool
  • Institutional Pamphlet
  • New York, New York
    NYU Langone Health
Nov 4, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

Completed
Has Results
  • Cancer of Kidney
  • +6 more
  • 124-Iodine-cG250 (124I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Renal Cancer Trial in New York (124IcG250)

Active, not recruiting
  • Renal Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Kidney Cancer DNA Registry

Recruiting
  • Renal Cancer
  • salvia for germline DNA
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Apr 1, 2022

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Renal Cancer Trial in United States ((EORTC QLQ-C30) questionnaire, EuroQol EQ-5D 7-item questionnaire)

Active, not recruiting
  • Renal Cancer
  • (EORTC QLQ-C30) questionnaire
  • EuroQol EQ-5D 7-item questionnaire
  • Los Angeles, California
  • +5 more
Feb 23, 2022

Ascertainment of Families for Genetic Studies of Familial

Recruiting
  • Lymphoma
  • +4 more
    • Basking Ridge, New Jersey
    • +5 more
    Oct 7, 2021

    Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

    Completed
    Has Results
    • Breast Cancer
    • +15 more
    • Encinitas, California
    • +23 more
    Sep 20, 2018

    Renal Cancer Trial in New York (mannitol, )

    Completed
    Has Results
    • Renal Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 13, 2018

    Renal Cancer Trial in New York (BEZ235)

    Terminated
    Has Results
    • Renal Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2016

    Renal Cancer Trial in New York (percutaneous cryoablation)

    Completed
    • Renal Cancer
    • percutaneous cryoablation
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 4, 2016

    Renal Cancer, Kidney Cancer Trial in New York (Ultrasound with intravenous microbubble contrast injection)

    Completed
    • Renal Cancer
    • Kidney Cancer
    • Ultrasound with intravenous microbubble contrast injection
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Dec 23, 2015

    Adrenal Cortical Cancer, Brain Cancer, Breast Cancer Trial in New York (Proton-decoupled 31P MRS at 1.5T, 1H Spectroscopy at

    Completed
    • Adrenal Cortical Cancer
    • +18 more
    • Proton-decoupled 31P MRS at 1.5T
    • 1H Spectroscopy at 1.5T and 3T
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Dec 23, 2015

    Cervical Cancer, HEENT Cancer, Renal Cancer Trial in New York (124I-Iodo-Azomycin Galacto-Pyranoside)

    Completed
    • Cervical Cancer
    • +5 more
    • 124I-Iodo-Azomycin Galacto-Pyranoside
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Dec 23, 2015